tecoimage tecoimage tecoimage tecoimage
tecoimage tecoimage
DE | FR | EN | PRINT
tecoimage tecoimage
tecoimage tecoimage tecoimage
tecoimage tecoimage tecoimage
tecoimage
tecoimage tecoimage tecoimage
tecoimage

Bone metabolism Product details

Productname Osteocalcin (1-43/49) N-MID human
Cat-No. KT-809
Range 4 - 64 ng/ml
Sensitivity 0.3 ng/ml
Incubation time 1.5 hours
Sample volume 25 μl
Sample type

serum, plasma

Sample preparation

Separate serum or plasma within 3 hours after blood collection.
Specimens may be stored at 2-8°C for 6 days. For longer storage
keep at -20°C. Max. 3 freeze and thaw cycles. Avoid hemolysis.

Reference values
  Range (ng/ml) Mean (ng/ml)
Healthy adults
(n=40)
3.8 – 25.3 11.7 (median 11.4 ng/ml;
                SD 3.8 ng/ml)
95 percentile cut-off: 17 ng/ml
Premenopausal 5.4 - 15.2 10.3
Postmenopausal 3.9 - 21.6 13.8
Men 5.4 - 15.1 10.8
Endstage renal disease
patients (n=39)
21 - 119 60.6 (median 59.6 ng/ml;
               SD 26.2 ng/ml)


 

Species

Human

Tests 96 Tests
Method ELISA
Product informations - Cross-reaction all species (pdf-File 71 kb)
- Bone & Cartilage Metabolism (pdf-File 2480 kb)
Intended use

Osteocalcin can be helpful as a biochemical marker for bone turnover. Increased concentrations are found in patients with different bone diseases that are marked by increased osteoblast activity.

• Paget’s disease
• Osteomalacia
• Bone fibrosis
• Renal osteodystrophy
• Follow up of osteoporosis treatment

Increased osteocalcin levels were found in patients with elevated levels of thyroid hormones, growth hormones, vitamin D and parathyroid hormones.

Medical Devices, Angiogenese, Tierassays, Spezielle Parameter, Knochenstoffwechsel, Kalziumstoffwechsel, KnorpelstoffwechselBack to overview      print view
tecoimage tecoimage
tecoimage tecoimage tecoimage tecoimage
 
tecoimage tecoimage tecoimage tecoimage